Pth-containing therapeutic/prophylactic agent for osteoporosis, characterized in that pth is administered once a week in a unit dose of 100 to 200 units
AssigneeAsahi Kasei Pharma Corporation
InventorsShinichiro Shirae, Yasuo Nakamura, Yuiko Oya, Yoshihide Nozaki, Nobuyuki Kobayashi, Tatsuhiko Kuroda, Hiroki Kato, Masashi Serada, Kazuyoshi Hori
Life of this patent
Estimating the term…